Graf Akcie CPIX (Cumberland Pharmaceuticals Inc.). Diskuze k akciím CPIX. Aktuální informace CPIX.

Základní informace o společnosti Cumberland Pharmaceuticals Inc. (Akcie CPIX)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 40.88M
Hodnota podniku (EV) 29.4M
Tržby 39.105M
EBITDA -107.93
Zisk 29.876k
Růst v tržbách Q/Q -5.65 %
Růst v tržbách Y/Y -6.85 %
P/E (Cena vůči ziskům) 1,364.69
Forward P/E 0.04
EV/Sales 0.75
EV/EBITDA N/A
EV/EBIT 133.39
PEG 1.12
Price/Sales 1.02
P/FCF 8.53
Price/Book 0.85
Účetní hodnota na akcii 3.22
Hotovost na akcii 1.70
FCF vůči ceně 11.72 %
Počet zaměstnanců 90
Tržba na zaměstnance 434.499k
Profit margin -8.92 %
Operating margin -12.06 %
Gross margin 76.89 %
EBIT margin 0.56 %
EBITDA margin -0.28 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -100.00 %
EPS - Očekávaný růst příští rok -300.00 %
Return on assets 0.03 %
Return on equity 0.06 %
ROIC -3.00 %
ROCE 0.31 %
Dluhy/Equity 1.06
Čistý dluh/EBITDA 307.51
Current ratio 2.50
Quick Ratio 1.43
Volatilita 4.20
Beta 0.22
RSI 48.39
Cílová cena analytiků 9
Známka akcie (dle analytiků) N/A
Insider ownership 43.23 %
Institutional ownership 21.67 %
Počet akcií 14.88M
Procento shortovaných akcií 1.18 %
Short ratio 3.83 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2009
Země United States

Finanční výsledky akcie CPIX

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$47.534$40.742$41.15$33.026$33.519$36.902
Cost Of Goods Sold$8.752$7.378$7.371$5.959$4.968$5.053
Gross Profit$38.782$33.364$33.78$27.067$28.551$31.849
Research And Development Expenses$6.479$7.576$4.28$3.191$3.848$3.389
SG&A Expenses$31.792$30.409$31.144$23.115$21.602$23.304
Other Operating Income Or Expenses------
Operating Expenses$51.157$48.133$45.232$34.459$32.407$33.343
Operating Income$-3.623$-7.391$-4.081$-1.433$1.112$3.559
Total Non-Operating Income/Expense$-0.003$0.369$0.206$0.098$0.135$0.184
Pre-Tax Income$-3.626$-7.022$-3.875$-1.335$1.247$3.743
Income Taxes$-0.079$0.017$4.175$-0.331$0.576$1.381
Income After Taxes$-3.547$-7.039$-8.05$-1.004$0.671$2.363
Other Income------
Income From Continuous Operations$-3.547$-7.039$-8.05$-1.004$0.671$2.363
Income From Discontinued Operations------
Net Income$-3.538$-6.963$-7.979$-0.945$0.731$2.424
EBITDA$0.781$-4.408$-1.434$0.964$3.358$5.548
EBIT$-3.623$-7.391$-4.081$-1.433$1.112$3.559
Basic Shares Outstanding151616161718
Shares Outstanding151616161718
Basic EPS$-0.23$-0.45$-0.50$-0.06$0.04$0.14
EPS - Earnings Per Share$-0.23$-0.45$-0.50$-0.06$0.04$0.14
# 2020 2019 2018 2017 2016 2015
Current Ratio2.07712.12623.88174.43115.20345.1504
Long-term Debt / Capital0.26590.26470.13290.05310.0217-
Debt/Equity Ratio0.36210.35990.15330.05610.0221-
Gross Margin81.587781.890682.088681.957485.178186.3065
Operating Margin-7.622-18.1405-9.9182-4.33953.31649.6441
EBIT Margin-7.622-18.1405-9.9182-4.33953.31649.6441
EBITDA Margin1.6434-10.8195-3.48382.918310.019415.0356
Pre-Tax Profit Margin-7.6279-17.2357-9.4166-4.04193.720110.1437
Net Profit Margin-7.4426-17.0907-19.3891-2.86052.18196.568
Asset Turnover0.45470.36150.44140.35360.36470.3868
Inventory Turnover Ratio0.92990.61091.09391.10931.16350.9023
Receiveable Turnover4.85965.19384.90174.50555.51566.7037
Days Sales In Receivables75.109670.275674.464381.012966.175854.4478
ROE - Return On Equity-6.9423-12.6664-12.5933-1.3730.87362.9256
Return On Tangible Equity-18.392-33.3095-18.951-1.96981.20593.9917
ROA - Return On Assets-3.3922-6.2459-8.6341-1.07480.73012.4762
ROI - Return On Investment-5.0966-9.3142-10.9192-1.30010.85472.9256
Book Value Per Share3.34683.58964.06554.5494.68994.7171
Operating Cash Flow Per Share-0.00090.2344-0.0701-0.3087-0.03010.3332
Free Cash Flow Per Share0.01230.2226-0.0794-0.3084-0.02940.3294